Tranexamic Acid Versus Dexmedetomidine for Improving Surgical Field Quality During Spine Surgeries

NACompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

June 1, 2024

Study Completion Date

June 30, 2024

Conditions
Surgical Field Quality Improvement in Spine Surgeries
Interventions
DRUG

Tranexamic acid

Start IV infusion of a loading dose of tranexamic acid 10 mg/kg completed to 50 ml saline over 10 min before induction of anesthesia. IV infusion of tranexamic acid at a dose of 1 mg/kg/h immediately after induction till 15 min before the end of surgery.

DRUG

Dexmedetomidine

Start IV infusion of a loading dose of dexmedetomidine 1ug/kg completed to 50 ml saline over 10 min before induction of anesthesia. IV infusion of dexmedetomidine 0.3-0.7 µg/kg/h immediately after induction to maintain Mean Arterial Pressure (MAP) between 60-70 mmHg till 15 min before the end of surgery.

OTHER

Saline (NaCl 0,9 %) (placebo)

IV infusion of 50 ml saline over 10 min before induction of anesthesia. IV saline infusion immediately after induction till 15 min before the end of surgery.

Trial Locations (2)

44519

Faculty of medicine, zagazig university, Zagazig

Unknown

Zagazig University, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV

NCT06587620 - Tranexamic Acid Versus Dexmedetomidine for Improving Surgical Field Quality During Spine Surgeries | Biotech Hunter | Biotech Hunter